Indian drug major’s Laboratories Limited has reached a settlement with the US government agencies for $5 million in a six-year-old case regarding complaints of potential harm from the package of blister-packed prescription products to children.
In June last year, US Consumer Product Safety Commission(CPSC) has requested the US Department of Justice to impose civil penalty on Dr Reddy’s for alleged violations of provisions related to child-resistant packaging in at least five prescription drugs.
While disagreeing with these allegations, the company on Tuesday said it had chosen to settle the matter in order to avoid any unnecessary costs and the distractions of prolonged